Avestar Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$714K Sell
15,424
-1,308
-8% -$60.5K 0.05% 238
2025
Q1
$1.02M Buy
16,732
+1,842
+12% +$112K 0.09% 159
2024
Q4
$842K Buy
14,890
+3,575
+32% +$202K 0.07% 178
2024
Q3
$585K Buy
11,315
+4,293
+61% +$222K 0.06% 221
2024
Q2
$292K Sell
7,022
-3,065
-30% -$127K 0.03% 306
2024
Q1
$547K Buy
10,087
+4,184
+71% +$227K 0.06% 206
2023
Q4
$303K Buy
5,903
+197
+3% +$10.1K 0.03% 269
2023
Q3
$331K Buy
5,706
+1,719
+43% +$99.8K 0.05% 205
2023
Q2
$255K Sell
3,987
-795
-17% -$50.9K 0.04% 240
2023
Q1
$331K Buy
4,782
+5
+0.1% +$347 0.06% 194
2022
Q4
$344K Buy
4,777
+790
+20% +$56.9K 0.06% 173
2022
Q3
$283K Sell
3,987
-966
-20% -$68.6K 0.07% 181
2022
Q2
$381K Sell
4,953
-1,024
-17% -$78.8K 0.09% 137
2022
Q1
$437K Sell
5,977
-5,621
-48% -$411K 0.07% 215
2021
Q4
$723K Buy
11,598
+5,907
+104% +$368K 0.09% 142
2021
Q3
$337K Sell
5,691
-40,338
-88% -$2.39M 0.04% 240
2021
Q2
$3.08M Buy
46,029
+8,877
+24% +$593K 0.41% 39
2021
Q1
$2.45M Buy
37,152
+31,053
+509% +$2.05M 0.55% 31
2020
Q4
$378K Buy
+6,099
New +$378K 0.1% 178
2019
Q3
Sell
-1,560
Closed -$64K 254
2019
Q2
$64K Buy
1,560
+159
+11% +$6.52K 0.04% 263
2019
Q1
$63K Sell
1,401
-52
-4% -$2.34K 0.04% 256
2018
Q4
$72K Buy
1,453
+36
+3% +$1.78K 0.05% 218
2018
Q3
$84K Sell
1,417
-42
-3% -$2.49K 0.05% 212
2018
Q2
$77K Buy
1,459
+118
+9% +$6.23K 0.05% 235
2018
Q1
$82K Buy
1,341
+77
+6% +$4.71K 0.05% 192
2017
Q4
$75K Buy
+1,264
New +$75K 0.06% 195